Women's Cardiovascular Research Laboratory
Meet Our Team
Dr. Megan Wenner,PhD
Megan is an Assistant Professor in the Department of Kinesiology and Applied Physiology at the University of Delaware. She received her PhD from the University of Delaware and completed postdoctoral training at The John B. Pierce Laboratory. Her research focuses on women’s health and cardiovascular function. Her most recent work examines the impact of ovarian hormones on vascular signaling mechanisms in women throughout the lifespan, with a particular focus on Endothelin-1 (ET-1). She also investigates mechanisms regulating blood pressure in women, and through collaborations with Drs. William Farquhar and Sean Stocker, examines the effects of salt on blood pressure control.
Sangeetha Nathaniel, MBBS
Sangeetha received a Bachelor of Medicine and Bachelor of Surgery (MBBS) from Sri Ramachandra Medical College and Research Institute. She gained clinical experience in bothIndia and England in general medicine. She has an interest in women’s cardiovascular health, specifically postmenopausal women in relation to vascular function and hypertension. She also enjoys spending time with her family and loves to play the piano.
Andrew Kuczmarski, BS
Andrew received a degree with distinction from the University of Delaware, majoring in exercise science with minors in biology and biochemistry. He has previous research experience working for both the National Institutes on Aging and the Department for Defense. He is currently interested in translational research and women’s health. During his undergraduate he also pursued photography and has worked as a wedding photographer.
Joshua C. Hobson, MS, CBDT
Josh received both his Bachelor and Master of Science in Exercise Science from East Stroudsburg University of Pennsylvania. Prior to joining the University of Delaware as a Lab Coordinator, Josh served as a clinical research coordinator studying the secondary medical consequences of veterans with spinal cord injury, where he led studies in the Endocrine and Metabolism program focused on osteoporosis and adverse metabolic dysfunction. Josh is currently completing his PhD in Health Sciences from Rutgers University.